Effecting the combination of memantine and methylphenidate in children affected by attention deficit hyperactivity disorder

Comparison of the effects of different doses of memantine in combination with methylphenidate in children affected by attention deficit hyperactivity disorder

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100520003979N8

Enrollment

Registered

2018-09-22

Start date

2018-09-23

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorder, predominantly inattentive type

Interventions

Intervention 1: Intervention group 1: In this group, memantine is given at a dose of 0.1 to 0.25 mg / kg. In this group, with a minimum dose of memantine 0.1, it starts with ritalin, and gradually we

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age of children aged 6 to 12 years Having diagnostic criteria based on IV-IRDSM and Conners test

Exclusion criteria

Exclusion criteria: Another serious psychiatric disorder, such as schizophrenia, bipolar disorder A history of seizure and medical conditions such as cardiovascular problems and diabetes History of allergy for Memantine Failure to respond to Memantine Severe ritalin complications

Design outcomes

Primary

Measure	Time frame
Attention Deficit Hyperactivity Disorder. Timepoint: Befor intervention- the end of second, fourth and sixth,eighth, tenth,twelfth weeks of the study. Method of measurement: The Conner's parent rating scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForough Riahi

Ahvaz University of Medical Sciences

Riahi13@gmail.com+98 61 3374 3038

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026